These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 9075707)

  • 1. 1,25-dihydroxyvitamin D3 and 9-cis-retinoic acid act synergistically to inhibit the growth of LNCaP prostate cells and cause accumulation of cells in G1.
    Blutt SE; Allegretto EA; Pike JW; Weigel NL
    Endocrinology; 1997 Apr; 138(4):1491-7. PubMed ID: 9075707
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of vitamin D3 on keratinocyte proliferation and differentiation in vitro: modulation by ligands for retinoic acid and retinoid X receptors.
    Sørensen S; Sølvsten H; Politi Y; Kragballe K
    Skin Pharmacol; 1997; 10(3):144-52. PubMed ID: 9287395
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Novel 20-epi-vitamin D3 analog combined with 9-cis-retinoic acid markedly inhibits colony growth of prostate cancer cells.
    Elstner E; Campbell MJ; Munker R; Shintaku P; Binderup L; Heber D; Said J; Koeffler HP
    Prostate; 1999 Aug; 40(3):141-9. PubMed ID: 10398275
    [TBL] [Abstract][Full Text] [Related]  

  • 4. p53 Is required for 1,25-dihydroxyvitamin D3-induced G0 arrest but is not required for G1 accumulation or apoptosis of LNCaP prostate cancer cells.
    Polek TC; Stewart LV; Ryu EJ; Cohen MB; Allegretto EA; Weigel NL
    Endocrinology; 2003 Jan; 144(1):50-60. PubMed ID: 12488329
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prostate cancer cell type-specific involvement of the VDR and RXR in regulation of the human PTHrP gene via a negative VDRE.
    Sepulveda VA; Weigel NL; Falzon M
    Steroids; 2006 Feb; 71(2):102-15. PubMed ID: 16243370
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Retinoic acid modulates the anti-proliferative effect of 1,25-dihydroxyvitamin D3 in cultured human epidermal keratinocytes.
    Segaert S; Garmyn M; Degreef H; Bouillon R
    J Invest Dermatol; 1997 Jul; 109(1):46-54. PubMed ID: 9204954
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Retinoic acid via RARalpha inhibits the expression of 24-hydroxylase in human prostate stromal cells.
    Lou YR; Miettinen S; Kagechika H; Gronemeyer H; Tuohimaa P
    Biochem Biophys Res Commun; 2005 Dec; 338(4):1973-81. PubMed ID: 16289102
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antiproliferative effect of 1alpha,25-dihydroxyvitamin D3 in human prostate cancer cell line LNCaP involves reduction of cyclin-dependent kinase 2 activity and persistent G1 accumulation.
    Zhuang SH; Burnstein KL
    Endocrinology; 1998 Mar; 139(3):1197-207. PubMed ID: 9492054
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antiproliferative responses to two human colon cancer cell lines to vitamin D3 are differently modified by 9-cis-retinoic acid.
    Kane KF; Langman MJ; Williams GR
    Cancer Res; 1996 Feb; 56(3):623-32. PubMed ID: 8564982
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Induction of androgen receptor by 1alpha,25-dihydroxyvitamin D3 and 9-cis retinoic acid in LNCaP human prostate cancer cells.
    Zhao XY; Ly LH; Peehl DM; Feldman D
    Endocrinology; 1999 Mar; 140(3):1205-12. PubMed ID: 10067845
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Salt concentration determines 1,25-dihydroxyvitamin D3 dependency of vitamin D receptor-retinoid X receptor--vitamin D-responsive element complex formation.
    Kimmel-Jehan C; Jehan F; DeLuca HF
    Arch Biochem Biophys; 1997 May; 341(1):75-80. PubMed ID: 9143355
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Apoptosis is induced by the active metabolite of vitamin D3 and its analogue EB1089 in colorectal adenoma and carcinoma cells: possible implications for prevention and therapy.
    Díaz GD; Paraskeva C; Thomas MG; Binderup L; Hague A
    Cancer Res; 2000 Apr; 60(8):2304-12. PubMed ID: 10786699
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Vitamin D3- and retinoic acid-induced monocytic differentiation: interactions between the endogenous vitamin D3 receptor, retinoic acid receptors, and retinoid X receptors in U-937 cells.
    Botling J; Oberg F; Törmä H; Tuohimaa P; Bläuer M; Nilsson K
    Cell Growth Differ; 1996 Sep; 7(9):1239-49. PubMed ID: 8877104
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Expression of retinoic acid receptor-beta sensitizes prostate cancer cells to growth inhibition mediated by combinations of retinoids and a 19-nor hexafluoride vitamin D3 analog.
    Campbell MJ; Park S; Uskokovic MR; Dawson MI; Koeffler HP
    Endocrinology; 1998 Apr; 139(4):1972-80. PubMed ID: 9528984
    [TBL] [Abstract][Full Text] [Related]  

  • 15. All-trans and 9-cis retinoic acid enhance 1,25-dihydroxyvitamin D3-induced monocytic differentiation of U937 cells.
    Nakajima H; Kizaki M; Ueno H; Muto A; Takayama N; Matsushita H; Sonoda A; Ikeda Y
    Leuk Res; 1996 Aug; 20(8):665-76. PubMed ID: 8913320
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Combination treatment with 1alpha,25-dihydroxyvitamin D3 and 9-cis-retinoic acid directly inhibits human telomerase reverse transcriptase transcription in prostate cancer cells.
    Ikeda N; Uemura H; Ishiguro H; Hori M; Hosaka M; Kyo S; Miyamoto K; Takeda E; Kubota Y
    Mol Cancer Ther; 2003 Aug; 2(8):739-46. PubMed ID: 12939463
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Control of LNCaP proliferation and differentiation: actions and interactions of androgens, 1alpha,25-dihydroxycholecalciferol, all-trans retinoic acid, 9-cis retinoic acid, and phenylacetate.
    Esquenet M; Swinnen JV; Heyns W; Verhoeven G
    Prostate; 1996 Mar; 28(3):182-94. PubMed ID: 8628721
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Synergistic differentiation of U937 cells by all-trans retinoic acid and 1 alpha, 25-dihydroxyvitamin D3 is associated with the expression of retinoid X receptor alpha.
    Defacque H; Commes T; Sevilla C; Rochette-Egly C; Marti J
    Biochem Biophys Res Commun; 1994 Aug; 203(1):272-80. PubMed ID: 8074666
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Actions of vitamin D3, analogs on human prostate cancer cell lines: comparison with 1,25-dihydroxyvitamin D3.
    Skowronski RJ; Peehl DM; Feldman D
    Endocrinology; 1995 Jan; 136(1):20-6. PubMed ID: 7530193
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Interaction of two novel 14-epivitamin D3 analogs with vitamin D3 receptor-retinoid X receptor heterodimers on vitamin D3 responsive elements.
    Verlinden L; Verstuyf A; Quack M; Van Camp M; Van Etten E; De Clercq P; Vandewalle M; Carlberg C; Bouillon R
    J Bone Miner Res; 2001 Apr; 16(4):625-38. PubMed ID: 11315990
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.